Fulcrum Therapeutics Inc (FULC)
3.26
+0.05
(+1.56%)
USD |
NASDAQ |
Nov 04, 16:00
3.265
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bioventus Inc | 68.54% |
| Arcturus Therapeutics Holdings Inc | -- |
| Entrada Therapeutics Inc | -- |
| Johnson & Johnson | 69.01% |
| Insmed Inc | 77.34% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.07% |
| Return on Assets | -7.42% |
| Return on Invested Capital | -8.07% |
| Profit Margin (Quarterly) | 69.26% |
| Operating Margin (Quarterly) | 65.62% |
| Return on Net Operating Assets | -113.0% |